Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

In this video interview, Mike Rea explains why each drug needs its own launch strategy.

After nine months of speculation about who will be the next FDA commissioner, we may finally be close to a decision.

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

How is the field of antibody drug conjugates being reshaped?

Could mRNA vaccine be the flu interventions of tomorrow?

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

AI is expanding into medicine. Are the world’s regulators ready?

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.